These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

861 related items for PubMed ID: 15001626

  • 1. Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes.
    Storgaard H, Jensen CB, Björnholm M, Song XM, Madsbad S, Zierath JR, Vaag AA.
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1301-11. PubMed ID: 15001626
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion.
    Jessen N, Djurhuus CB, Jørgensen JO, Jensen LS, Møller N, Lund S, Schmitz O.
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E194-9. PubMed ID: 15339744
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Insulin secretion after short- and long-term low-grade free fatty acid infusion in men with increased risk of developing type 2 diabetes.
    Storgaard H, Jensen CB, Vaag AA, Vølund A, Madsbad S.
    Metabolism; 2003 Jul; 52(7):885-94. PubMed ID: 12870166
    [Abstract] [Full Text] [Related]

  • 6. Activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise.
    Beeson M, Sajan MP, Dizon M, Grebenev D, Gomez-Daspet J, Miura A, Kanoh Y, Powe J, Bandyopadhyay G, Standaert ML, Farese RV.
    Diabetes; 2003 Aug; 52(8):1926-34. PubMed ID: 12882907
    [Abstract] [Full Text] [Related]

  • 7. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
    Meyer MM, Levin K, Grimmsmann T, Beck-Nielsen H, Klein HH.
    Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Infusion of beta-endorphin improves insulin resistance in fructose-fed rats.
    Su CF, Chang YY, Pai HH, Liu IM, Lo CY, Cheng JT.
    Horm Metab Res; 2004 Aug; 36(8):571-7. PubMed ID: 15326568
    [Abstract] [Full Text] [Related]

  • 10. Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle.
    Kim YB, Zhu JS, Zierath JR, Shen HQ, Baron AD, Kahn BB.
    Diabetes; 1999 Feb; 48(2):310-20. PubMed ID: 10334307
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Glucose-fatty acid cycle operates in humans at the levels of both whole body and skeletal muscle during low and high physiological plasma insulin concentrations.
    Vaag AA, Handberg A, Skøtt P, Richter EA, Beck-Nielsen H.
    Eur J Endocrinol; 1994 Jan; 130(1):70-9. PubMed ID: 8124481
    [Abstract] [Full Text] [Related]

  • 13. Increased insulin receptor signaling and glycogen synthase activity contribute to the synergistic effect of exercise on insulin action.
    Christ-Roberts CY, Pratipanawatr T, Pratipanawatr W, Berria R, Belfort R, Mandarino LJ.
    J Appl Physiol (1985); 2003 Dec; 95(6):2519-29. PubMed ID: 12909611
    [Abstract] [Full Text] [Related]

  • 14. Insulin-stimulated insulin receptor substrate-2-associated phosphatidylinositol 3-kinase activity is enhanced in human skeletal muscle after exercise.
    Howlett KF, Sakamoto K, Yu H, Goodyear LJ, Hargreaves M.
    Metabolism; 2006 Aug; 55(8):1046-52. PubMed ID: 16839840
    [Abstract] [Full Text] [Related]

  • 15. Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients.
    Miyazaki Y, He H, Mandarino LJ, DeFronzo RA.
    Diabetes; 2003 Aug; 52(8):1943-50. PubMed ID: 12882909
    [Abstract] [Full Text] [Related]

  • 16. Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo.
    Park E, Wong V, Guan X, Oprescu AI, Giacca A.
    J Endocrinol; 2007 Nov; 195(2):323-31. PubMed ID: 17951543
    [Abstract] [Full Text] [Related]

  • 17. Growth hormone (GH)-induced insulin resistance is rapidly reversible: an experimental study in GH-deficient adults.
    Krusenstjerna-Hafstrøm T, Clasen BF, Møller N, Jessen N, Pedersen SB, Christiansen JS, Jørgensen JO.
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2548-57. PubMed ID: 21613350
    [Abstract] [Full Text] [Related]

  • 18. Intracellular glucose metabolism after long term metabolic control with glyburide: improved glucose oxidation with unchanged glycogen synthase activity.
    Suh KI, Murata C, Song YM, Joyce M, Gumbiner B, Ditzler TM, Henry RR.
    J Clin Endocrinol Metab; 1993 Aug; 77(2):464-70. PubMed ID: 8345053
    [Abstract] [Full Text] [Related]

  • 19. Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus.
    Mostad IL, Bjerve KS, Basu S, Sutton P, Frayn KN, Grill V.
    Metabolism; 2009 Dec; 58(12):1753-61. PubMed ID: 19716144
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.